{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T12:18:15Z","timestamp":1795177095056,"version":"4.10.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Invasive pulmonary aspergillosis (IPA) is seen during coronavirus-2019 (COVID-19), has been reported in different incidences, and is defined as COVID-19-associated pulmonary aspergillosis (CAPA). Detection of galactomannan antigen is an important diagnostic step in diagnosing IPA. Enzyme-linked immunoassay (ELISA) is the most frequently used method, and lateral flow assay (LFA) is increasingly used with high sensitivity and specificity for rapid diagnosis. The present study aimed to compare the sensitivity of LFA and ELISA in the diagnosis of CAPA in COVID-19 patients followed in our hospital's ICU for pandemic (ICU-P).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study included patients with a diagnosis of COVID-19 cases confirmed by polymerase chain reaction and were followed up in ICU-P between August 2021 and February 2022 with acute respiratory failure. The diagnosis of CAPA was based on the European Confederation of Medical Mycology (ECMM) and the International Society for Human and Animal Mycology 2020 (ECMM\/ ISHAM) guideline. Galactomannan levels were determined using LFA and ELISA in serum samples taken simultaneously from the patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Out of the 174 patients followed in the ICU-P, 56 did not meet any criteria for CAPA and were excluded from the analysis. The rate of patients diagnosed with proven CAPA was 5.7% (10 patients). A statistically significant result was obtained with LFA for the cut-off value of 0.5 ODI in the diagnosis of CAPA (p\u2009&lt;\u20090.001). The same significant statistical relationship was found for the cut-off value of 1.0 ODI for the ELISA (p\u2009&lt;\u20090.01). The sensitivity of LFA was 80% (95% CI: 0.55\u20131.05, p\u2009&lt;\u20090.05), specificity 94% (95% CI: 0.89\u20130.98, p\u2009&lt;\u20090.05); PPV 53% (95% CI: 0.28\u20130.79, p\u2009&gt;\u20090.05) and NPV was 98% (95% CI: 0.95\u20131.01, p\u2009&lt;\u20090.05). The risk of death was 1.66 (HR: 1.66, 95% CI: 1.02\u20132.86, p\u2009&lt;\u20090.05) times higher in patients with an LFA result of\u2009\u2265\u20090.5 ODI than those with\u2009&lt;\u20090.5 (p\u2009&lt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>It is reckoned that LFA can be used in future clinical practice, particularly given its effectiveness in patients with hematological malignancies and accuracy in diagnosing CAPA.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07828-y","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T20:11:52Z","timestamp":1667938312000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Lateral flow assay (LFA) in the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA): a single-center experience"],"prefix":"10.1186","volume":"22","author":[{"given":"Istemi","family":"Serin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevim","family":"Baltali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahir Alper","family":"Cinli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Goze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bur\u00e7ak","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"Yokus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,8]]},"reference":[{"key":"7828_CR1","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054\u201362.","journal-title":"Lancet"},{"key":"7828_CR2","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s15010-021-01602-z","volume":"49","author":"WH Chong","year":"2021","unstructured":"Chong WH, Saha BK, Ananthakrishnan R, Chopra A. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia. Infection. 2021;49:591\u2013605.","journal-title":"Infection"},{"key":"7828_CR3","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1111\/myc.13274","volume":"64","author":"JD Jenks","year":"2021","unstructured":"Jenks JD, Nam HH, Hoenigl M. Invasive aspergillosis in critically ill patients: review of definitions and diagnostic approaches. Mycoses. 2021;64:1002\u201314.","journal-title":"Mycoses"},{"key":"7828_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/jof6020091","volume":"6","author":"A Arastehfar","year":"2020","unstructured":"Arastehfar A, Carvalho A, van de Veerdonk FL, Jenks JD, Koehler P, Krause R, et al. COVID-19 associated pulmonary aspergillosis (CAPA)\u2014from immunology to treatment. J Fungi. 2020;6:91.","journal-title":"J Fungi"},{"key":"7828_CR5","doi-asserted-by":"crossref","unstructured":"Koehler P, Bassetti M, Chakrabarti A, Chen SCA, Colombo AL, Hoenigl M et al. European Confederation of Medical Mycology; International Society for Human and Animal Mycology; Asia Fungal Working Group; INFOCUS LATAM\/ISHAM Working Group; ISHAM Pan Africa Mycology Working Group; European Society for Clinical Microbiology; Infectious Diseases Fungal Infection Study Group; ESCMID Study Group for Infections in Critically Ill Patients; Interregional Association of Clinical Microbiology and Antimicrobial Chemotherapy; Medical Mycology Society of Nigeria; Medical Mycology Society of China Medicine Education Association; Infectious Diseases Working Party of the German Society for Haematology and Medical Oncology; Association of Medical Microbiology; Infectious Disease Canada. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021; 21: 149\u2013162.","DOI":"10.1016\/S1473-3099(20)30847-1"},{"key":"7828_CR6","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1093\/cid\/ciaa1342","volume":"73","author":"M Hoenigl","year":"2021","unstructured":"Hoenigl M. Invasive Fungal Disease Complicating Coronavirus Disease 2019: When It Rains. It Spores Clin Infect Dis. 2021;73:1645\u20138.","journal-title":"It Spores Clin Infect Dis"},{"key":"7828_CR7","doi-asserted-by":"crossref","unstructured":"Bartoletti M, Pascale R, Cricca M, Rinaldi M, Maccaro A, Bussini L et al.; PREDICO Study Group. Epidemiology of invasive pulmonary aspergillosis among intubated patients with COVID-19: a prospective study. Clin Infect Dis. 2021; 73: 3606\u20133614.","DOI":"10.1093\/cid\/ciaa1065"},{"key":"7828_CR8","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s11046-020-00493-2","volume":"185","author":"E Nasri","year":"2020","unstructured":"Nasri E, Shoaei P, Vakili B, Mirhendi H, Sadeghi S, Hajiahmadi S, et al. Fatal invasive pulmonary aspergillosis in COVID-19 patient with acute myeloid leukemia in Iran. Mycopathologia. 2020;185:1077\u201384.","journal-title":"Mycopathologia"},{"key":"7828_CR9","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.3201\/eid2711.211174","volume":"27","author":"NAF Janssen","year":"2021","unstructured":"Janssen NAF, Nyga R, Vanderbeke L, Jacobs C, Erg\u00fcn M, Buil JB, et al. Multinational observational cohort study of COVID-19-associated pulmonary aspergillosis1. Emerg Infect Dis. 2021;27:2892\u20138.","journal-title":"Emerg Infect Dis"},{"key":"7828_CR10","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1164\/rccm.202004-1038LE","volume":"202","author":"ALE van Arkel","year":"2020","unstructured":"van Arkel ALE, Rijpstra TA, Belderbos HNA, van Wijngaarden P, Verweij PE, Bentvelsen RG. COVID-19\u2013associated pulmonary aspergillosis. Am J Respir Crit Care Med. 2020;202:132\u20135.","journal-title":"Am J Respir Crit Care Med"},{"key":"7828_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13613-020-00686-4","volume":"10","author":"L Rutsaert","year":"2020","unstructured":"Rutsaert L, Steinfort N, Van Hunsel T, Bomans P, Naesens R, Mertes H, et al. COVID-19-associated invasive pulmonary aspergillosis. Ann Intensive Care. 2020;10:71.","journal-title":"Ann Intensive Care"},{"key":"7828_CR12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s13054-020-03046-7","volume":"24","author":"J Wang","year":"2020","unstructured":"Wang J, Yang Q, Zhang P, Sheng J, Zhou J, Qu T. Clinical characteristics of invasive pulmonary aspergillosis in patients with COVID-19 in Zhejiang, China: a retrospective case series. Crit Care. 2020;24:299.","journal-title":"Crit Care"},{"key":"7828_CR13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S2213-2600(20)30237-X","volume":"8","author":"A Alanio","year":"2020","unstructured":"Alanio A, Delli\u00e8re S, Fodil S, Bretagne S, M\u00e9garbane B. Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19. Lancet Respir Med. 2020;8:48\u20139.","journal-title":"Lancet Respir Med"},{"key":"7828_CR14","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/j.cmi.2020.07.010","volume":"26","author":"F Lamoth","year":"2020","unstructured":"Lamoth F, Glampedakis E, Boillat-Blanco N, Oddo M, Pagani JL. Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients. Clin Microbiol Infect. 2020;26:1706\u20138.","journal-title":"Clin Microbiol Infect"},{"key":"7828_CR15","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/cid\/ciaa1298","volume":"73","author":"PL White","year":"2021","unstructured":"White PL, Dhillon R, Cordey A, Hughes H, Faggian F, Soni S, et al. A national strategy to diagnose coronavirus disease 2019\u2014associated invasive fungal disease in the intensive care unit. Clin Infect Dis. 2021;73:1634\u201344.","journal-title":"Clin Infect Dis"},{"key":"7828_CR16","first-page":"1","volume":"27","author":"S Delli\u00e8re","year":"2020","unstructured":"Delli\u00e8re S, Dudoignon E, Fodil S, Voicu S, Collet M, Oillic PA, et al. Risk factors associated with COVID-19\u2014associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort. Clin Microbiol Infect. 2020;27:1\u20135.","journal-title":"Clin Microbiol Infect"},{"key":"7828_CR17","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1136\/thoraxjnl-2014-206291","volume":"70","author":"C Kosmidis","year":"2015","unstructured":"Kosmidis C, Denning DW. The clinical spectrum of pulmonary aspergillosis. Thorax. 2015;70:270\u20137.","journal-title":"Thorax"},{"key":"7828_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12281-017-0275-8","volume":"11","author":"S Heldt","year":"2017","unstructured":"Heldt S, Hoenigl M. Lateral flow assays for the diagnosis of invasive aspergillosis: current status. Curr Fungal Infect Rep. 2017;11:45\u201351.","journal-title":"Curr Fungal Infect Rep"},{"key":"7828_CR19","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1093\/cid\/ciaa295","volume":"72","author":"T Mercier","year":"2021","unstructured":"Mercier T, Guldentops E, Lagrou K, Maertens J. Prospective evaluation of the turbidimetric \u03b2-D-glucan assay and 2 lateral flow assays on serum in invasive Aspergillosis. Clin Infect Dis. 2021;72:1577\u201384.","journal-title":"Clin Infect Dis"},{"key":"7828_CR20","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/myc.13265","volume":"64","author":"I Serin","year":"2021","unstructured":"Serin I, Dogu MH. Serum Aspergillus galactomannan lateral flow assay for the diagnosis of invasive aspergillosis: a single-centre study. Mycoses. 2021;64:678\u201383.","journal-title":"Mycoses"},{"key":"7828_CR21","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s10459-010-9222-y","volume":"15","author":"G Norman","year":"2010","unstructured":"Norman G. Likert scales, levels of measurement and the \u201claws\u201d of statistics. Adv Health Sci Educ Theory Pract. 2010;15:625\u201332.","journal-title":"Adv Health Sci Educ Theory Pract"},{"key":"7828_CR22","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cmi.2022.01.027","volume":"28","author":"RM Kariyawasam","year":"2022","unstructured":"Kariyawasam RM, Dingle TC, Kula BE, Vandermeer B, Sligl WI, Schwartz IS. Defining COVID-19-associated pulmonary aspergillosis: systematic review and meta-analysis. Clin Microbiol Infect. 2022;28:920\u20137.","journal-title":"Clin Microbiol Infect"},{"key":"7828_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jhin.2021.04.012","volume":"113","author":"WH Chong","year":"2021","unstructured":"Chong WH, Neu KP. Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review. J Hosp Infect. 2021;113:115\u201329.","journal-title":"J Hosp Infect"},{"key":"7828_CR24","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01689-21","volume":"60","author":"B Autier","year":"2022","unstructured":"Autier B, Prattes J, White PL, Valerio M, Machado M, Price J, et al. Aspergillus lateral flow assay with digital reader for the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA): a multicenter study. J Clin Microbiol. 2022;60: e0168921.","journal-title":"J Clin Microbiol"},{"key":"7828_CR25","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/myc.13518","volume":"65","author":"M Ghazanfari","year":"2022","unstructured":"Ghazanfari M, Yazdani Charati J, Davoodi L, Arastehfar A, Moazeni M, Abastabar M, et al. Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID-19-associated pulmonary aspergillosis. Mycoses. 2022;65:960\u20138.","journal-title":"Mycoses"},{"key":"7828_CR26","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1111\/myc.13352","volume":"64","author":"M Hoenigl","year":"2021","unstructured":"Hoenigl M, Egger M, Boyer J, Schulz E, Prattes J, Jenks JD. Serum lateral flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: a two-centre mixed cohort study. Mycoses. 2021;64:1197\u2013202.","journal-title":"Mycoses"},{"key":"7828_CR27","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S2213-2600(21)00442-2","volume":"10","author":"JP Gangneux","year":"2022","unstructured":"Gangneux JP, Dannaoui E, Fekkar A, Luyt CE, Botterel F, De Prost N, et al. Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study. Lancet Respir Med. 2022;10:180\u201390.","journal-title":"Lancet Respir Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07828-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07828-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07828-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T20:12:04Z","timestamp":1667938324000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07828-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,8]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["7828"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07828-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,8]]},"assertion":[{"value":"5 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical committee approval was received (Istanbul Training and Research Hospital, approval date, and number: 28\/01\/2022-28), and the patients or their relatives gave informed consent before the beginning of the study. The experimental procedures were based on the Declaration of Helsinki and relevant institutional regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared that they do not have any competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"822"}}